• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[聚乙二醇严重速发型超敏反应病例中ARN COVID-19 辉瑞疫苗脱敏治疗]

[ARN COVID-19 COMIRNATY Vaccine desensitization in a case of PEG Severe Immediate Hypersensitivity].

作者信息

Huynh V A, Janssen C, Beaumier L

机构信息

Service d'allergologie, Centre Hospitalier Annecy-Genevois, 1, avenue de l'Hôpital, 74370 Epagny Metz-Tessy, France.

Service Infectiologie, Centre Hospitalier Annecy-Genevois, 1, avenue de l'Hôpital, 74370 Epagny Metz-Tessy, France.

出版信息

Rev Fr Allergol (2009). 2022 May;62(4):431-434. doi: 10.1016/j.reval.2021.07.007. Epub 2021 Aug 28.

DOI:10.1016/j.reval.2021.07.007
PMID:34484471
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8400452/
Abstract

Vaccination is the most efficient way to fight the Covid epidemic. However, suspicion of severe hypersensitivity to PEG (PolyEthylen Glycol) usually constitutes a vaccine contraindication. We report the case of a patient with a proven allergy to PEG and skin sensitization to the COMIRNATY vaccine (PEG in its composition). He was able to benefit from the vaccine under the 5-step desensitization protocol. Conclusions: Specific allergological management should be offered to patients suspected of severe hypersensitivity to PEG and other vaccine excipients. We propose a solution for Comirnaty administration for patients with a proven severe allergy to PEG.

摘要

接种疫苗是对抗新冠疫情最有效的方法。然而,怀疑对聚乙二醇(PEG)有严重超敏反应通常构成疫苗接种禁忌。我们报告了一例对PEG过敏且对COMIRNATY疫苗(其成分中含有PEG)皮肤致敏的患者病例。他能够在五步脱敏方案下接种该疫苗。结论:对于怀疑对PEG和其他疫苗辅料有严重超敏反应的患者,应提供特定的变应性疾病管理。我们为已证实对PEG严重过敏的患者提出了COMIRNATY疫苗的接种解决方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08b8/8400452/bf99c0f488cb/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08b8/8400452/bf99c0f488cb/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08b8/8400452/bf99c0f488cb/gr1_lrg.jpg

相似文献

1
[ARN COVID-19 COMIRNATY Vaccine desensitization in a case of PEG Severe Immediate Hypersensitivity].[聚乙二醇严重速发型超敏反应病例中ARN COVID-19 辉瑞疫苗脱敏治疗]
Rev Fr Allergol (2009). 2022 May;62(4):431-434. doi: 10.1016/j.reval.2021.07.007. Epub 2021 Aug 28.
2
Successful Desensitization to mRNA COVID-19 Vaccine in a Case Series of Patients With a History of Anaphylaxis to the First Vaccine Dose.在一系列对第一剂新冠病毒mRNA疫苗有过敏反应病史的患者中成功实现脱敏
Front Allergy. 2022 Feb 2;3:825164. doi: 10.3389/falgy.2022.825164. eCollection 2022.
3
Experience with polyethylene glycol allergy-guided risk management for COVID-19 vaccine anaphylaxis.聚乙二醇过敏导向的 COVID-19 疫苗过敏反应风险管理经验。
Allergy. 2022 Jul;77(7):2200-2210. doi: 10.1111/all.15183. Epub 2021 Dec 4.
4
Successful mRNA COVID-19 Vaccination and Colonoscopy After Oral Desensitization in a Patient With Polyethylene Glycol Allergy.聚乙二醇过敏患者口服脱敏后成功接种 mRNA COVID-19 疫苗并完成结肠镜检查。
J Korean Med Sci. 2022 Aug 15;37(32):e251. doi: 10.3346/jkms.2022.37.e251.
5
Hypersensitivity to polyethylene glycol (PEG).对聚乙二醇(PEG)过敏。
Folia Med Cracov. 2021 Dec 28;61(4):55-69. doi: 10.24425/fmc.2021.140004.
6
Patients with previous immediate hypersensitivity reactions to polyethylene glycol can safely receive the BNT162b2 mRNA COVID-19 vaccine.曾有对聚乙二醇即刻过敏反应的患者可以安全地接种 BNT162b2 mRNA COVID-19 疫苗。
Intern Med J. 2022 Oct;52(10):1818-1820. doi: 10.1111/imj.15821. Epub 2022 Oct 6.
7
The role of skin tests with polyethylene glycol and polysorbate 80 in the vaccination campaign for COVID-19: results from an Italian multicenter survey.聚乙二醇和聚山梨醇酯 80 皮肤试验在 COVID-19 疫苗接种运动中的作用:来自意大利多中心调查的结果。
Eur Ann Allergy Clin Immunol. 2024 Jan;56(1):17-25. doi: 10.23822/EurAnnACI.1764-1489.291. Epub 2023 Mar 16.
8
AstraZeneca ChAdOx1-S COVID-19 vaccine can be safely administered in patients with EDTA allergy.阿斯利康ChAdOx1-S型新冠疫苗可安全用于对乙二胺四乙酸(EDTA)过敏的患者。
Allergy Asthma Clin Immunol. 2022 Mar 10;18(1):22. doi: 10.1186/s13223-022-00665-3.
9
Allergies and COVID-19 vaccines: An ENDA/EAACI Position paper.过敏与 COVID-19 疫苗:ENDA/EAACI 立场文件。
Allergy. 2022 Aug;77(8):2292-2312. doi: 10.1111/all.15241. Epub 2022 Mar 5.
10
First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.mRNA COVID-19 疫苗首剂过敏反应:赋形剂皮肤试验作用有限。
J Allergy Clin Immunol Pract. 2021 Sep;9(9):3308-3320.e3. doi: 10.1016/j.jaip.2021.06.010. Epub 2021 Jun 22.

引用本文的文献

1
Desensitization Protocols for Anti-SARS-CoV-2 Vaccines in Patients with High Risk of Allergic Reactions.过敏反应高风险患者中抗SARS-CoV-2疫苗的脱敏方案
Vaccines (Basel). 2023 Apr 27;11(5):910. doi: 10.3390/vaccines11050910.
2
[Suspected allergy to COVID-19 vaccines: A retrospective study of 320 patients].[对新冠疫苗的疑似过敏反应:320例患者的回顾性研究]
Rev Fr Allergol (2009). 2023 Mar;63(2):103303. doi: 10.1016/j.reval.2023.103303. Epub 2023 Jan 19.
3
PEG allergy - A COVID-19 pandemic-made problem? A German perspective.

本文引用的文献

1
Anaphylaxis associated with the mRNA COVID-19 vaccines: Approach to allergy investigation.与 mRNA COVID-19 疫苗相关的过敏反应:过敏反应调查方法。
Clin Immunol. 2021 Jun;227:108748. doi: 10.1016/j.clim.2021.108748. Epub 2021 Apr 28.
2
Administration of a Second Dose of the Moderna COVID-19 Vaccine After an Immediate Hypersensitivity Reaction With the First Dose: Two Case Reports.首剂 Moderna COVID-19 疫苗立即发生超敏反应后接种第二剂:两例病例报告
Ann Intern Med. 2021 Aug;174(8):1177-1178. doi: 10.7326/L21-0104. Epub 2021 Apr 6.
3
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines.
聚乙二醇过敏——新冠疫情引发的问题?德国视角。
World Allergy Organ J. 2022 Nov;15(11):100714. doi: 10.1016/j.waojou.2022.100714. Epub 2022 Oct 31.
4
Allergological study in patients vaccinated against COVID-19 with suspected allergic reactions.对接种新冠疫苗后出现疑似过敏反应患者的变态反应学研究。
Allergy Asthma Clin Immunol. 2022 May 27;18(1):43. doi: 10.1186/s13223-022-00685-z.
欧洲过敏与临床免疫学会关于严重 COVID-19 疫苗过敏反应的诊断、管理和预防的声明
Allergy. 2021 Jun;76(6):1629-1639. doi: 10.1111/all.14739.
4
Clinical manifestations and impact on daily life of allergy to polyethylene glycol (PEG) in ten patients.十名对聚乙二醇(PEG)过敏患者的临床表现及对日常生活的影响。
Clin Exp Allergy. 2021 Mar;51(3):463-470. doi: 10.1111/cea.13822. Epub 2021 Jan 15.
5
mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach.mRNA 疫苗预防 COVID-19 疾病和报告的过敏反应:当前证据和建议方法。
J Allergy Clin Immunol Pract. 2021 Apr;9(4):1423-1437. doi: 10.1016/j.jaip.2020.12.047. Epub 2020 Dec 31.
6
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.两种基于 RNA 的新冠候选疫苗的安全性和免疫原性。
N Engl J Med. 2020 Dec 17;383(25):2439-2450. doi: 10.1056/NEJMoa2027906. Epub 2020 Oct 14.
7
A 12-steps desensitization protocol for pediatric patients with hypersensitivity to pegylated asparaginase.针对对聚乙二醇化天冬酰胺酶过敏的儿科患者的12步脱敏方案。
Ann Allergy Asthma Immunol. 2020 Feb;124(2):208-210. doi: 10.1016/j.anai.2019.11.001. Epub 2019 Nov 14.
8
Immediate Hypersensitivity to Polyethylene Glycols and Polysorbates: More Common Than We Have Recognized.对聚乙二醇和聚山梨酯的即刻过敏反应:比我们认识到的更为常见。
J Allergy Clin Immunol Pract. 2019 May-Jun;7(5):1533-1540.e8. doi: 10.1016/j.jaip.2018.12.003. Epub 2018 Dec 14.
9
Immediate-type hypersensitivity to polyethylene glycols: a review.对聚乙二醇的速发型超敏反应:综述
Clin Exp Allergy. 2016 Jul;46(7):907-22. doi: 10.1111/cea.12760.
10
A New Era for Drug Desensitizations.
J Allergy Clin Immunol Pract. 2015 Jul-Aug;3(4):639-40. doi: 10.1016/j.jaip.2015.05.006.